Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis

Archives of Dermatology

Volumn 142, Issue 2, 2006, Pages 155-161

  Bahrami, Soon ^a   Malone, Janine C ^a   Webb, Kelli G ^a   Callen, Jeffrey P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMOXICILLIN; ANTIBIOTIC AGENT; CEFUROXIME; CELECOXIB; CLARITHROMYCIN; DOXYCYCLINE; GATIFLOXACIN; LEVOFLOXACIN; METOPROLOL; ROFECOXIB; SPIRONOLACTONE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CALCULATION; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIA; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LEUKOCYTOCLASTIC VASCULITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL RECORD; PRIORITY JOURNAL; RANK SUM TEST; RETROSPECTIVE STUDY; SKIN DISEASE; SMALL VESSEL VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOPSY; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; EOSINOPHILIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN; VASCULITIS, ALLERGIC CUTANEOUS;

EID: 33244482014     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.142.2.155     Document Type: Article

References (31)

1. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med. 1978;89:660-676.
2. Hunder GG, Arend WP, Block DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum. 1990;33:1065-1067.
3. Zeek PM. Periarteritis nodosa: a critical review. Am J Clin Pathol. 1952;22:777-790.
4. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum. 1994;37:187-192.
5. Sams WM Jr, Thorne G, Small P, Mass MF, McIntosh RM, Stanford RE. Leukocytoclastic vasculitis. Arch Dermatol. 1976;112:219-226.
6. Mackel SE, Jordan RE. Leukocytoclastic vasculitis: a cutaneous expression of immune complex disease. Arch Dermatol. 1982;118:296-301.
7. Lie JT; American College of Rheumatology Subcommittee on Classification of Vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum. 1990;33:1074-1087.
8. Gibson LE. Cutaneous vasculitis: approach to diagnosis and systemic associations. Mayo Clin Proc. 1990;65:221-229.
9. Ekenstam Eaf, Callen JP. Cutaneous leukocytoclastic vasculitis: clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol. 1984;120:484-489.
10. Sanchez NP, Van Hale HM, Su WPD. Clinical and histopathologic spectrum of necrotizing vasculitis: report of findings in 101 cases. Arch Dermatol. 1985;121:220-224.
11. Jessop SJ. Cutaneous leucocytoclastic vasculitis: a clinical and aetiological study. Br J Rheumatol. 1995;34:942-945.
12. Lowry MD, Hudson CF, Callen JP. Leukocytoclastic vasculitis caused by drug additives. J Am Acad Dermatol. 1994;30:854-855.
13. Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M. Cutaneous vasculitis in children and adults: associated diseases and etiologic factors in 303 patients. Medicine. 1998;77:403-418.
14. Martinez-Taboada VM, Blanco R, Garcia-Fuentes M, Rodriguez-Valverde V. Clinical features and outcomes of 95 patients with hypersensitivity vasculitis. Am J Med. 1997;102:186-191.
15. Garcia-Porrua C, Llorca J, Gonzalez-Louzao C, Gonzalez-Gay MA. Hypersensitivity vasculitis in adults: a benign disease usually limited to the skin. Clin Exp Rheumatol. 2001;19:85-88.
16. Mullick FG, McAllister HA, Wagner BM, Fenoglio JJ Jr. Drug related vasculitis: clinicopathologic correlations in 30 patients. Hum Pathol. 1979;10:313-325.
17. Zeek PM, Smith CC, Weeter JC. Studies on periarteritis nodosa, III: the differentiation between the vascular lesions of periarteritis nodosa and hypersensitivity. Am J Pathol. 1948;24:889-917.
18. Winkelmann RK, Ditto WB. Cutaneous and visceral syndromes of necrotizing or "allergic" angiitis: a study of 38 cases. Medicine. 1964;43:59-89.
19. Sais G, Vidaller A, Jucgla A, Servitje O, Condom E, Peyri J. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol. 1998;134:309-315.
20. Hodge SJ, Callen JP, Ekenstam E. Cutaneous leukocytoclastic vasculitis: correlation of histopathological changes with clinical severity and course. J Cutan Pathol. 1987;14:279-284.
21. Sams WM Jr. Hypersensitivity angiitis. J Invest Dermatol. 1989;93:78S-81S.
22. Zax RH, Hodge SJ, Callen JP. Cutaneous leukocytoclastic vasculitis: serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. Arch Dermatol. 1990;126:69-72.
23. Gower RG, Sams WM Jr, Thorne EG, Kohler PF, Claman HN. Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol. 1977;69:477-484.
24. Cribier B, Couilliet D, Meyer P, Grosshans E. The severity of histopathological changes of leukocytoclastic vasculitis is not predictive of extracutaneous involvement. Am J Dermatopathol. 1999;21:532-536.
25. Garcia-Porrua C, Gonzalez-Gay MA, Lopez-Lazaro L. Drug associated cutaneous vasculitis in adults in northwestern Spain. J Rheumatol. 1999;26:1942-1944.
26. Callen JP. Cutaneous vasculitis: what have we learned in the past 20 years? Arch Dermatol. 1998;134:355-357.
27. Tosca N, Stratigos JD. Possible pathogenetic mechanisms in allergic cutaneous vasculitis. Int J Dermatol. 1988;27:291-296.
28. Sais G, Vidaller A, Jucgla A, Condom E, Peyri J. Adhesion molecule expression and endothelial cell activation in cutaneous vasculitis: an immunohistologic and clinical study in 42 patients. Arch Dermatol. 1997;133:443-450.
29. Burrows NP, Molina FA, Terenghi G, et al. Comparison of cell adhesion molecule expression in cutaneous leucocytoclastic and lymphocytic vasculitis. J Clin Pathol. 1994;47:939-944.
30. Jennette JC, Falk RJ. Medical progress: small-vessel vasculitis. N Engl J Med. 1997;337:1512-1523.
31. Calabrese LH, Duna GF. Drug-induced vasculitis. Curr Opin Rheumatol. 1996;8:34-40.